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ABSTRACT
Both epidemiological and experimental studies suggest that ethanol may 
enhance aggressiveness of breast cancer. We have previously demonstrated that 
short term exposure to ethanol (12–48 hours) increased migration/invasion in 
breast cancer cells overexpressing ErbB2, but not in breast cancer cells with low 
expression of ErbB2, such as MCF7, BT20 and T47D breast cancer cells. In this study, 
we showed that chronic ethanol exposure transformed breast cancer cells that were 
not responsive to short term ethanol treatment to a more aggressive phenotype. 
Chronic ethanol exposure (10 days - 2 months) at 100 (22 mM) or 200 mg/dl (44 mM) 
caused the scattering of MCF7, BT20 and T47D cell colonies in a 3-dimension culture 
system. Chronic ethanol exposure also increased colony formation in an anchorage-
independent condition and stimulated cell invasion/migration. Chronic ethanol 
exposure increased cancer stem-like cell (CSC) population by more than 20 folds. 
Breast cancer cells exposed to ethanol in vitro displayed a much higher growth rate 
and metastasis in mice. Ethanol selectively activated p38γ MAPK and RhoC but not 
p38α/β in a concentration-dependent manner. SP-MCF7 cells, a derivative of MCF7 
cells which compose mainly CSC expressed high levels of phosphorylated p38γ MAPK. 
Knocking-down p38γ MAPK blocked ethanol-induced RhoC activation, cell scattering, 
invasion/migration and ethanol-increased CSC population. Furthermore, knocking-
down p38γ MAPK mitigated ethanol-induced tumor growth and metastasis in mice. 
These results suggest that chronic ethanol exposure can enhance the aggressiveness 
of breast cancer by activating p38γ MAPK/RhoC pathway.
INTRODUCTION
Breast cancer is the second leading cause of 
cancer among American women [1]. Although the exact 
etiology for breast cancer initiation and development is 
unclear, environmental factors play an important role. 
Epidemiological studies indicate that alcohol consumption 
significantly increases the risk for breast cancer in a 
concentration- and duration-dependent manner [2–4]. In 
addition to the promotion of breast cancer carcinogenesis, 
alcohol may also enhance the growth of existing breast 
tumors and increase the aggressiveness of breast cancer 
cells to invade and metastasize [5–7]. Nonetheless, 
the underlying mechanisms are unknown. Various 
experimental models have been employed to investigate 
the effect of alcohol on breast cancer. The epidemiological 
data are supported by experimental studies which show 
that alcohol promotes mammary tumorigenesis/metastasis 
in animals, stimulates migration/invasion of breast 
tumor cells and enhances the expression of markers for 
epithelial-mesenchymal transition in cell culture systems 
[8–22].
Previous studies show that short-term treatment of 
alcohol, that is, exposure for 12–48 hours, is sufficient 
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to alter the behaviors of breast cancer cells, resulting in 
enhanced aggressiveness. However, breast cancer cells 
display differential sensitivity to alcohol exposure, that is, 
some cells are much more sensitive to alcohol exposure 
and some are not responsive [15]. For example, the short-
term alcohol exposure stimulates the migration/invasion 
of breast cancer cells expressing high levels of ErbB2/
HER2 [8, 12–15]. This may result from alcohol-induced 
amplification of ERbB2 signaling. However, some 
breast cancer cells, particularly the breast cells that 
express low levels of ErbB2, such as MCF7, T47D and 
BT20 cells, are quite resistant to alcohol exposure; the 
short-term treatment of alcohol has little effect on their 
migration/invasion behavior. We hypothesize that a long-
term treatment of alcohol is required to convert these 
“alcohol-resistant” cells to a more aggressive phenotype. 
In this study, we showed that long- term treatment of 
alcohol, 10 days-2 months, significantly increased the 
migration/invasion, cancer stem-like cell population and 
tumorigenicity in “alcohol-resistant” cells in vitro and in 
vivo. We further demonstrated that p38γ MAPK played 
an important role in alcohol-promoted aggressiveness in 
these cells. p38γ MAPK is one of four members of the 
p38 MAPK family [23]. Recent studies indicate that 
p38γ MAPK is implicated in breast cancer progression 
and aggressiveness [24]. We showed here that alcohol 
selectively activated p38γ MAPK and its down-stream 
effector, RhoC, resulting in enhanced aggressiveness of 
breast cancer cells.
RESULTS
Ethanol converts less aggressive breast cancer 
cells to a more aggressive phenotype
MCF7 cells are a less aggressive breast cancer line 
and display modest invasion and metastatic potential. 
Our previous study indicated that the short term ethanol 
exposure (12–48 hours) had little effect on the behaviors 
of MCF7 breast cancer cells [15]. We first examined 
the effect of chronic ethanol exposure on MCF7 cells. 
MCF7 cells were exposed to ethanol (100 or 200 mg/
dl) for 10 days~2 months at concentrations relevant 
to human alcohol consumption and then grown in an 
ethanol-free 3-D Matrigel system for an additional 10 
days. It was reported that aggressive breast cancer cells, 
such as MB231, have a property to grow to scattering 
spheroids in 3-D culture system [24]. Ethanol increased 
the scattering of MCF7 cells in a concentration- and 
duration-dependent manner (Figure 1A) which indicated 
an enhanced aggressiveness. The continuous presence 
of ethanol after chronic exposure further increased the 
scattering (Figure 1B). A similar effect of ethanol on 
T47D and BT20 breast cancer cells was observed (Figure 
1C). Both T47D and BT20 cells are less aggressive and 
barely respond to short term ethanol exposure [14, 15], 
but chronic ethanol exposure increased the scattering 
of these cells (Figure 1C). Noscattering spheroids were 
observed in control MCF7, T47D and BT20 cells. 
Chronic ethanol exposure-enhanced malignancy was 
also supported by the increase in anchorage-independent 
colony formation (Figure 1D). In addition, chronic ethanol 
exposure increased the migration/invasion of MCF7 cells 
(Figure 2). In this experiment, MCF7 cells were exposed 
to ethanol (100 mg/dl) for 10 days, 1 month or 2 months, 
and then assayed for their migration/invasion during a 
12 hour-period in an ethanol free environment. Chronic 
ethanol exposure significantly increased migratory 
(Figure 2A) and invasive potential of MCF7 cells (Figure 
2C); however, only the effect of ethanol on invasion was 
duration-dependent. Continuous ethanol presence in the 
medium further increased the migration/invasion (Figure 
2B and 2D). Once again, it was confirmed that short-
term ethanol exposure failed to alter migration/invasion 
of MCF7 cells (comparing the solid bars in Figure 2B 
and 2D: control versus acute ethanol exposure). Chronic 
ethanol exposure caused a modest decrease in cell number; 
this may result from either a slight inhibition of cell 
proliferation or decrease in cell viability (Figure 2E). Next, 
we tested the effect of ethanol on T47D and BT20 cells. 
Similar to MCF7 cells, we have previously demonstrated 
that both T47D and BT20 cells were insensitive to acute 
ethanol exposure due to low ErbB2 expression [15]. Here, 
we confirmed that short-term ethanol exposure (12 hours) 
did not affect the migration of T47D and BT20 cells 
(Figure 3A and 3C); however, chronic ethanol exposure 
(10 days) significantly increased the migration of these 
cells (Figure 3B and 3D).
We further demonstrated that chronic ethanol 
exposure significantly increased cancer stem-like cell 
population (Figure 4). In this experiment, MCF7 cells 
were exposed to ethanol (100 or 200 mg/dl) for 10 days 
and then evaluated for the stem-like cell population. 
Ethanol caused a concentration-dependent increase in 
stem-like cell population.
Breast cancer cells pre-exposed to ethanol 
display higher tumorigenicity in vivo
To confirm that chronic ethanol exposure indeed 
converted breast cancer cells to a more malignant phenotype, 
we treated MCF7 cells with ethanol (0 or 100 mg/dl) for 
a month and then xenografted these cells in to nude mice. 
Our data showed that MCF7 cells that were pretreated with 
ethanol exhibited significantly higher tumorigenicity (Figure 
5A) and tumor growth rate (Figure 5B).
Chronic ethanol exposure selectively activates 
p38γ MAPK
p38γ MAPK has been implicated in the 
aggressiveness of breast cancer cells (32). In animal 
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Figure 1: Effects of chronic ethanol exposure on the malignancy of breast cancer cells. A. MCF7 cells were exposed to 
ethanol (0, 100, or 200 mg/dl, i.e., 0, 22 or 44 mM) for 10 days, 1 month or 2 months. After ethanol exposure, single cell suspension 
(103 cells/well) was cultured in Matrigel and maintained in an ethanol free environment for 10 days as described in Materials and Methods 
B. After chronic exposure to ethanol, single cell suspension was cultured in Matrigel and maintained with ethanol (100 mg/dl) for 10 days. 
C. T47D or BT20 cells were exposed to ethanol (0 or 100 mg/dl) for 10 days, then cultured in ethanol-free Matrigel for an additional 
10 days. D. MCF7 cells were exposed to ethanol (0 or 100 mg/dl) for 10 days and then maintained in an ethanol-free soft agar assay for a 
month. Number of colonies/well was counted. Each data point was the mean ± SEM of three independent experiments. * denotes significant 
difference from controls, bar = 50 μm.
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Figure 2: Effects of chronic ethanol exposure on cell migration/invasion. MCF7 cells were exposed to ethanol (0 or 100 mg/
dl) for 10 days, 1 month or 2 months. After that, the migration A. and invasion C. were assayed during a 12 hour period in an ethanol free 
environment. In other experiments, MCF7 cells were exposed to ethanol (0 or 100 mg/dl) for 10 days, the migration B. and invasion D. were 
assayed in the presence or absence of ethanol (100 mg/dl) during a 12 hour period. After ethanol exposure, cell viability was determined 
by MTT assay as described in the Experimental procedures E. Each data point was the mean ± SEM of three independent experiments 
and presented relative to the control values. * denotes significant difference from no ethanol-treated control groups. # denotes significant 
difference from 10 day-ethanol-treated groups.
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studies, we showed that tumors developed by ethanol 
pre-exposed MCF7 cells exhibited higher expression 
of phospho-p38γ MAPK (Figure 5C), suggesting that 
p38γ MAPK may be involved in ethanol-promoted 
aggressiveness. We first investigated whether chronic 
ethanol exposure activated p38γ MAPK. Using the 
immunoprecipitation assay withcommercial antibodies, 
we showed that chronic ethanol exposure increased the 
phosphorylation of p38γ MAPK in MCF7 cells, but not 
other isoforms of p38 MAPK (Figures 6A–6C). Only 
results on p38α are presented and the data on other 
isoforms are not shown. In contrast, the short term ethanol 
exposure (0.5–12 hours) did not alter the phosphorylation 
of p38γ MAPK (Figure 6D). To further validate the 
finding, we generated a phospho-specific antibody 
directed against p38γ MAPK with the assistance of 21st 
Century Biochemical (Marlboro, MA). This antibody was 
specific for phospho-p38γ MAPK and did not cross react 
Figure 3: Effects of chronic ethanol exposure on T47D and BT20 cells. Equal amounts of T47D A. or BT20 C. cells were 
assayed for their migration ability with short term ethanol (0 or 100 mg/dl) exposure (12 hours). T47D B. or BT20 cells D. were exposed 
to ethanol (0 or 100 mg/dl) for 10 days, then equal amount of cells were assayed for their migration ability during a 12 hour period in an 
ethanol free environment. Each data point was the mean ± SEM of three independent experiments and presented relative to the control 
values. * denotes significant difference from no ethanol-treated control groups.
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with other p38 MAPK isoforms (Figure 6E). Using this 
antibody, we confirmed that chronic ethanol exposure 
specifically increased the phosphorylation of p38γ MAPK 
(Figure 6F). Using this antibody, we compared the levels 
of phosphorylated p38γ MAPK between MCF7 cells and 
its derivative, SP-MCF7 cells, a Hoechst dye excluding 
mammary cell subline which have more cancer stem-like 
cell population [25–27]. As shown in Figure 6G, SP-
MCF7 cells expressed more phosphorylated p38γ MAPK 
than MCF7 cells.
p38γ MAPK mediates ethanol-increased 
aggressiveness of breast cancer cells
To confirm the involvement of p38γ MAPK in 
ethanol-enhanced aggressiveness of breast cancer cells, 
we established MCF7 cells with a stable expression 
of either control shRNA (Consh) or shRNA for p38γ 
MAPK (p38γsh) (Figure 7A). Knocking down p38γ 
MAPK inhibited ethanol-induced cell scattering in the 
3-D culture system (Figure 7B) and the anchorage-
independent colony formation (Figure 7C). Knocking 
down p38γ MAPK also blocked ethanol-stimulated 
cell migration (Figure 8A) and invasion (Figure 8B). 
Furthermore, knocking down p38γ MAPK inhibited an 
ethanol-induced increase in stem-like cell population 
(Figure 8C). Down-regulation of p38γ MAPK did not 
alter cell viability (Figure 8D).
The critical role of ethanol-induced aggressiveness 
of breast cancer was further confirmed in animal studies. 
MCF7 cells expressing control shRNA or shRNA 
for p38γ were exposed to ethanol (100 mg/dl) for a 
month and then inoculated to nude mice. As shown 
in Figure 9A, expression of shRNA for p38γ MAPK 
significantly blocked ethanol-stimulated tumor growth 
in nude mice. Furthermore, the knock down p38γ MAPK 
by the shRNA blocked ethanol-induced lung metastasis 
(Figures 9B and 9C).
Mechanisms underlying p38γ MAPK-mediated 
aggressiveness of breast cancer cells
RhoC is a key protein that mediates the cell shape 
and motility and is implicated in the aggressiveness of 
breast cancer [28, 29]. It has been reported that p38γ 
MAPK may regulate the levels of RhoC by controlling 
its degradation [24]. We first sought to determine 
whether ethanol altered the levels of RhoC and then 
to investigate the role of p38γ MAPK in ethanol-
induced alteration of RhoC. As shown in Figure 10A, 
chronic ethanol exposure increased the levels of RhoC 
in MCF7 cells. Knocking down p38γ MAPK blocked 
ethanol-mediated increase of RhoC (Figure 10B). 
p38γ MAPK may alter RhoC levels by regulating its 
ubiquitin-dependent degradation [24]. We showed that 
ethanol decreased the ubiquitination of RhoC and down-
Figure 4: Effects of chronic ethanol exposure on stem-like cell population. MCF7 cells were exposed to ethanol (0, 100 or 200 
mg/dl) for 10 days, and then stem-like cell population was determined by the ALDEFLUOR as described in Materials and Methods. Data 
were presented as fold increase relative to the controls. * denotes significant difference from control groups.
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Figure 5: Effects of chronic ethanol exposure on tumorigenesis in vivo. MCF7 cells were exposed to ethanol (0 or 100 mg/
dl) for a month, then xenografted into nude mice as described in the Experimental procedures. A. Ethanol-pretreated cells ranging from 
103 to 106 cells/100 μl in PBS were subcutaneously inoculated into the lower flank of nude mice (n = 6). One month after inoculation, 
tumorigenicity was evaluated and presented as percentage of the original inoculation. *p < 0.05. B. Tumor sizewas measured weekly and 
tumor volume (mm3) was calculated as described in the Experimental procedures. *p < 0.05. C. Tumor tissues from control or ethanol-
exposed groups were fixed, sectioned and processed for IHC staining of phospho-p38γ (p-p38γ).
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regulation of p38γ MAPK increased the ubiquitination 
of RhoC (Figure 10C). Together, these results suggested 
that ethanol-mediated p38γ MAPK activation inhibited 
ubiquitination of RhoC, resulting in increased in RhoC 
levels. To confirm the role of RhoC in ethanol-induced 
aggressiveness, we knocked down RhoC expression by 
specific siRNA and examined the effect of ethanol on the 
migration/invasion of MCF7 cells. As shown in Figures 
10D and 10E, RhoC siRNA effectively inhibited ethanol-
induced migration and invasion, confirming that it played 
a critical role in ethanol-induced aggressiveness of breast 
cancer cells.
Figure 6: Effect of chronic ethanol exposure on the phosphorylation of p38γ MAPK. MCF7 cells were exposed to ethanol (0 
or 100 mg/dl) for 10 days, 1 month or 2 months. A. Cell lysates were collected and then equal amount of proteins were immuoprecipitated 
(IP) with an anti-p38γ MAPK antibody and then immunoblotted (IB) with an antibody directed against pan phosphorylated p38 MAPK 
(p-p38). B. Proteins were IP with an anti p-p38 antibody and then IB with an anti-p38α antibody. C. MCF7 cells were exposed to ethanol 
(0, 100, 200 or 400 mg/dl) for indicated times, then proteins were collected and IP with an anti-p-p38 antibody and IB with an anti-p38γ 
MAPK antibody. D. MCF7 cells were exposed to ethanol (100 mg/dl) for 0.5–12 hours. The expression of phosphorylated p38γ MAPK, 
total p38γ MAPK and RhoC was determined by immunoblotting. E. Equal amount of proteins were IP with p38γ or p38α, and then IB with 
either a commercial anti-pan phosphorylated p38 antibody (p-p38) or a specific anti-phosphorylated-p38γ antibody (p-p38γ) (21st Century 
Biochemical, please see Materials and Methods). F. The same protein samples described on panel A was analyzed with immunoblotting 
using the specific anti-p-p38γ MAPK antibody. G. The expression of phosphorylated p38γ in MCF7 and SP-MCF7 cells was evaluated 
using a specific anti-p-p38γ antibody as described above. All experiments were replicated at least three times.
Oncotarget3497www.impactjournals.com/oncotarget
DISCUSSION
We demonstrate here that chronic exposure to ethanol 
can transform breast cancer cells that do not normally 
respond to short-term exposure to a more aggressive 
phenotype. This is demonstrated by a significant increase in 
the scattering of these cells in the aggressive 3-dimensional 
growth, more colony formation in an anchorage-
independent condition, enhanced cell invasion/migration 
and higher CSC population following chronic exposure 
to ethanol (10 days – 2 months). This is also evident by 
the finding that the breast cancer cells chronically exposed 
Figure 7: Effects of p38γ knock-down on ethanol-induced malignancy. We have established MCF7 cells stably expressing 
control shRNA (Consh) and p38γ shRNA (p38γsh) as described in the Materials and Methods. The expression of p38γ and p38α was 
examined with immunoblotting A. These cells were exposed to ethanol (100 mg/dl) for 10 days then assayed for cell scattering in a 3-D 
culture system B. and anchorage-independent colonies formation C. The results were presented relative to the controls. Each data point 
was the mean ± SEM of three experiments. * denotes significant difference from control groups. # denotes significant difference from p38γ 
shRNA EtOH groups.
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to ethanol in vitro display a much higher rate of growth 
and metastasis in mice. It appears that p38γ MAPK plays 
an important role in ethanol-promoted aggressiveness. 
Knocking-down p38γ MAPK blocks ethanol-stimulated 
cell scattering, invasion/migration, an increase in CSC 
population as well as in vivo tumor growth and metastasis.
We have previously demonstrated that short term 
exposure to ethanol (12–48 hours) increased migration/
invasion in breast cancer cells overexpressing ErbB2, but 
not in breast cancer cells with low expression of ErbB2, 
such as MCF7, BT20 and T47D breast cancer cells [15]. 
The current study indicates that given enough time ethanol 
can stimulate breast cancer cells that are not responsive 
to short term ethanol exposure. It appears the effect of 
ethanol is not reversible at least in the present experimental 
models. This is demonstrated by the results that the effect 
of ethanol on cell scattering, colony formation, migration/
invasion and CSC population is persistent even after the 
removal of ethanol. Similarly, it appears that breast cancer 
cells treated with ethanol in vitro have acquired greater 
potential to grow and metastasize in mice that are free of 
ethanol exposure. It is noted that continuous presence of 
ethanol further enhances the stimulatory effect of chronic 
ethanol exposure (Figures 1B, 2B and 2D).
Figure 8: Effects of p38γ knock-down on ethanol-induced migration/invasion and cancer stem-like cell population. MCF7 
cells stably expressing control shRNA (Consh) and p38γ shRNA (p38γsh) were exposed to ethanol (0 or 100 mg/dl) for 10 days. After 
that, cell migration A. invasion B. cancer stem-like cell population C. and cell viability D. were evaluated as described in the Materials 
and Methods. The results were expressed relative to the controls. Each data point was the mean ± SEM of three experiments. * denotes 
significant difference from control groups. # denotes significant difference from ethanol-treated p38γsh groups.
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Figure 9: Effects of p38γ knock-down on ethanol-induced tumor growth and metastasis. MCF7 cells stably expressing 
control shRNA and shRNA for p38γ MAPK (p38γsh) were exposed to ethanol (0 or 100 mg/dl) for a month, then 5 × 106 cells (in 100 
ul PBS) were inoculated into nude mice on both sides of the lower flank as described in the Materials and Methods. A. Four weeks after 
inoculation, the tumors were measured and the average volume was calculated. * denotes significant difference from mice inoculated 
with MCF7 cells. # denotes significant difference from mice inoculated with MCF7 cells expressing p38γ shRNA. B. At completion of 
experiments, mice were sacrificed and analyzed for tumor metastasis as described in the Materials and Methods. C. Lung tissues were fixed, 
sectioned and stained. The image shows metastatic carcinomas in the lungs of mice that were inoculated with ethanol-treated MCF7 cells.
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We have previously shown that short-term exposure 
to ethanol can stimulate the phosphorylation of p38 MAPK 
in breast cancer cells overexpressing ErbB2, but not in 
cells expressing low levels of ErbB2 [15]. However, in 
that study we did not differentiate which isoforms of p38 
MAPK were being activated by ethanol. Consistent with 
the previous finding, our current results confirm that short-
term ethanol exposure does not elicit phosphorylation of 
Figure 10: Effects of chronic ethanol exposure on RhoC expression. A. MCF7 cells were exposed to ethanol (0, 100, 200 or 400 
mg/dl) for 10 days, 1 month or 2 months, then the expression of RhoC was examined by immunoblotting. B. MCF7 cells stably expressing 
control shRNA and p38γ shRNA (p38γsh) were exposed to ethanol (0 or 100 mg/dl) for 10 days. After that, cell lysates were IP with an 
anti-p38γ antibody, and then IB with an anti p-p38 MAPK antibody. The expression of RhoC was examined. C. Cell lysates were IP with 
an anti-ubiquitin antibody and IB with an anti-RhoC antibody. D. MCF7 cells were exposed to ethanol (0 or 100 mg/dl) for 10 days, and 
then treated with either control siRNA or RhoC siRNA for 48 hours. After that, cells were assayed for the migration during a 12-hour-period 
with/without ethanol (100 mg/dl). E. Cell invasion was evaluated. Each data point was the mean ± SEM of three experiments and presented 
relative to the controls values. * denotes significant difference from the controls. # denotes significant difference from long term EtOH (LT 
EtOH). δ denotes significant difference from corresponding controls.
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p38 MAPK in MCF7 cells (Figure 6D). Instead, we show 
that chronic ethanol exposure specifically increases the 
phosphorylation of p38γ MAPK but not other isoforms 
of p38 (Figure 6). The effect of ethanol on p38γ MAPK 
phosphorylation parallels its effect on cell behaviors, that 
is, only chronic exposure to ethanol has stimulatory effects 
on cell scattering, colony formation, migration/invasion 
and CSC population.
The p38 MAPK family is comprised of four 
members, p38α, p38β, p38γ and p38δ. The first isoform 
p38α was identified in 1994 as a 38 kDa polypeptide 
that is activated in response to endotoxin treatment, cell 
stress or cytokines [23]. Three additional isoforms were 
described later: p38β, p38γ and p38δ. These kinases 
share highly similar protein sequences; p38α and p38β 
are 75% identical, whereas p38γ and p38δ are 62% and 
61% identical to p38α, respectively. In turn, p38γ and 
p38δ are 70% identical to each other. The four p38MAPK 
isoforms are widely expressed, although p38β, p38γ and 
p38δ expression appear to be higher in specific tissues; 
for example, p38β is abundant in brain, p38γ in skeletal 
muscle, and p38δ in endocrine glands [23]. In general, all 
p38MAPKs are strongly activated by a wide variety of 
environmental and cellular stresses or by inflammatory 
cytokines and are poorly activated by serum or growth 
factors [23]. The canonical activation of p38 MAPKs 
occurs via dual phosphorylation of their Thr–Gly–Tyr 
motif, in the activation loop, by mitogen-activated protein 
kinase kinase (MKK) 3/6 (MKK3 and MKK6) [23]. Upon 
activation, the dually phosphorylated p38MAPK goes 
through characteristic global conformational changes that 
alters the alignment of the two kinase halves (N-terminal 
and C-terminal domains) of the folded protein and 
enhances access to the substrate, which together increases 
enzymatic activity. To date, most studies of the p38MAPK 
pathways focused on function of the p38α and p38β 
isoform, which is widely considered to negatively regulate 
malignant transformation; nonetheless, few reports address 
the p38γ and p38δ isoforms. Although p38γ and p38δ can 
phosphorylate typical p38 MAPK substrates such as the 
transcription factors ATF2, Elk-1 or SAP1, they cannot 
phosphorylate some substrates of p38α and p38β and have 
their unique substrates [23] .
Recent studies indicate that p38γ may have some 
particular implications in breast cancer. For example, 
Meng et al. [30] showed that p38γ is overexpressed in 
highly metastatic human and mouse breast cancer cell lines 
and p38γ expression is preferentially associated with basal-
like and metastatic phenotypes of breast tumor samples. 
Clinical evidence shows that elevated expression of p38γ 
is associated with lower overall survival of patients with 
breast cancer [24]. Using a computational mechanical 
model, Rosenthal et al further showed that p38γ can 
regulate the changes of cytoskeleton and cell shape of 
breast cancer cells and control cell motility. This evidence 
suggests an important role of p38γin the aggressiveness of 
breast cancer. However, it is unclear how p38γ is activated 
and how itregulates the aggressiveness of breast cancer 
cells. It is reported that p38γ can regulate RhoC expression 
by mediating RhoC protein stability through regulation of 
RhoC ubiquitination and lysosomal degradation [24]. We 
demonstrate that ethanol-induced activation of p38γinhibits 
the ubiquitination of RhoC, therefore increasing the 
stability of RhoC protein (Figure 10). More importantly, 
down-regulation of RhoC is sufficient to inhibit ethanol-
induced migration and invasion in MCF7 cells. This 
suggests that p38γ and RhoC pathway plays an important 
role in ethanol-promoted aggressiveness of breast cancer.
It is currently unclear regarding the mechanisms of 
how ethanol specifically activates p38γ. One possibility 
is that the effect of ethanol is mediated through the 
production of reactive oxygen species (ROS). Mitogen-
activated protein kinase kinase 6 (MKK6) is the major 
upstream kinase that activate p38γ and its activity is 
regulated by intracellular ROS concentration [31]. MKK6 
activation in turn can enhance ROS production through 
NADPH oxidase [32]. Ethanol oxidation produces ROS. 
Although ethanol metabolism mainly occurs in the liver 
and is mediated by hepatic alcohol dehydrogenase IB 
(ADH1B), breast cancer cells are shown to express 
moderate levels of cytochrome P450 2E1, another enzyme 
to oxidize ethanol. We have previously demonstrated 
that ethanol increases intracellular ROS accumulation in 
breast cancer cells [15, 21]. Therefore, it is possible that 
ethanol activates ROS-p38γ-RhoC pathway which results 
in enhanced aggressiveness of breast cancer.
MATERIALS AND METHODS
Materials
Protein A/G beads were obtained from Santa 
Cruz Biotechnology (San Diego, CA). Polyclonal anti-
phospho-p38 MAPK (Thr180/Tyr182) antibody was 
purchased from Life Technologies (Carlsbad, CA) 
and Cell Signaling Technology Inc. (Beverly, MA). 
Anti-p38α, p38β, p38γ MAPK and RhoC antibodies 
were purchased from Santa Cruz Biotechnology (San 
Diego, CA). Anti-GAPDH antibody was obtained from 
Research Diagnostics, Inc. (Concord, MA). MTT assay 
kit was purchased from Roche Molecular Biochemicals 
(Indianapolis, IN). p38γ shRNA, control shRNA, RhoC 
siRNA and control siRNA were purchased from Santa 
Cruz Biotechnology (San Diego, CA). Matrigel Matrix 
basement membrane and Matrigel Invasion Chambers 
were purchased from BD Biosciences (Bedford, MA). 
Transwell was obtained from Costar Corp. (Acton, 
MA). ALDEFLUOR kits were purchased from Stemcell 
Technologies (Vancouver, Canada). Antibiotic-Antimycotic 
(Anti-Anti) and cell culture mediums were obtained from 
Gibco (Life Technologies). All other chemicals were 
obtained from Sigma-Aldrich (St. Louis, MO).
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Cell culture and ethanol exposure
MCF7 and T47D were grown in DMEM medium 
containing 10% fetal bovine serum (FBS) and 1% Anti-
Anti. BT20 cells were cultured in EMEM medium 
containing 10% FBS, 1% Anti-Anti, 3 mM glucose 
and 2 mM glutamine. SP-MCF7 (side population-
MCF7) cells, a Hoechst dye excluding mammary cell 
subline, were a gift from Dr. Xiuwei Yang (University 
of Kentucky). Cells were maintained at 37°C with 5% 
CO2. A range of physiologically relevant concentrations 
of ethanol (0, 100, 200, or 400 mg/dl, i.e., 0, 22, 44 or 
88 mM) was used in this study. Ethanol at 100 mg/dl 
(22 mM) was used in the most experiments. A method 
utilizing sealed containers was used to maintain ethanol 
concentrations in the culture medium. With this method, 
ethanol concentrations in the culture medium can be 
accurately maintained [33]. The containers were placed 
in a humidified environment and maintained at 37°C with 
5% CO2.
Generation of phospho-specific antibody against 
p38γ MAPK
Affinity-purified antibodies specifically against 
the dual-phosphorylation motif, Thr-Gly-Tyr [34] which 
is located in the activation loop [Thr(p) 180/Tyr(p) 
182) on p38γ MAPK] were generated at 21st Century 
Biochemicals (Marlboro, MA). Rabbits were immunized 
with the phosphorylated p38γ peptide Acetyl-SEM[pT]
G[pY]VVT-Ahx-C-amide and serum was affinity 
purified.
Generation of cells stably expressing p38γ 
shRNA
To generate stable cell lines with silencing of 
p38γ, briefly, MCF7 cells were transfected with either 
scrambled short hairpin RNA (shRNA) as controls or 
shRNA for p38γ MAPK (Santa Cruz Biotechnology) using 
a Neon Transfection apparatus (Life Technologies). Cells 
expressing these shRNA were selected by the treatment 
of puromycin (4 μg/ml). Cell lysates were collected and 
the down-regulation of p38γ MAPK was confirmed by 
immunoblotting.
Three-dimensional cell culture assay
The three-dimensional (3-D) cell culture system 
was established as previously described [35]. Briefly, 24-
well plates were pre-coated with 150 μl Matrigel Matrix 
(BD Biosciences). Single cell suspension (103 per well) 
were mixed with 200 μl ice-cold Matrigel and seeded 
in the pre-coated 24-well plates. After 30 min gelling, 
culture medium was added to the plates and the medium 
was changed every 2 to 3 days. The cell morphology was 
captured by a Zeiss Axiovert 40C photomicroscope.
Immunoblotting and immunoprecipitation
Cells were lysed in modified RIPA buffer (150 
mM NaCl, 50 mM Tris, 1% NP-40, 0.25% sodium 
deoxycholate) containing 1 mM sodium vanadate, 1 
mM phenylmethanesulfonyl fluoride (PMSF), 5 μg/ml 
of aprotinin, and 2 μg/ml of leupeptin. The procedure 
for immunoblotting has been previously described (27). 
Briefly, protein samples were clarified by centrifugation 
at 14,000 rpm for 10 min at 4°C and resolved by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE). The separated proteins were transferred 
to nitrocellulose membranes. The membranes were 
probed with the indicated primary antibodies, followed 
by the appropriate horseradish peroxidase-conjugated 
secondary antibodies, and developed by enhanced 
chemiluminescence.
For immunoprecipitation, equal amount of proteins 
(about 500–800 μg) were incubated with anti-p38γ, 
p38α, phosphorylated-p38 (p-p38), phosphorylated-p38γ 
(p-p38γ) or ubiquitin antibodies at 4°C overnight. The 
protein/antibody complex was treated with Protein A/G 
beads conjugated to agarose at 4°C for 4 hours, and then 
centrifuged at 5,000 g for 5 min. Samples were washed 
5 times with RIPA buffer, 1 time with cold-TBS, and 
then boiled in sample buffer (187.5 mM Tri-HCl, pH 
6.8, 6% SDS, 30% glycerol, 150 mM DTT and 0.03% 
bromophenol blue). Proteins were resolved in SDS PAGE 
and analyzed by immunoblotting.
MTT assay
The MTT assay was performed to determine the 
number of viable cells as previously described [21]. 
Briefly, equal amount of cells were plated into 96-
well plates and cultured for 24 hours. After that, 10 μl 
of MTT reagent was added to each well and the plates 
were incubated at 37°C for 4 hours. The cultures were 
solubilized and spectrophotometric absorbance was 
measured at 595 nm using a microtiter platereader 
(Beckman coulter).
Cell invasion and migration
Cell invasion was assayed using Matrigel Invasion 
Chambers (BD Biosciences). Cell migration was 
analyzed using a Transwell Migration System (Costar). 
Briefly, equal amount of cells were placed on the upper 
compartment of invasion chambers or Transwell chambers 
(8.0 μm pore size) which contained serum-free medium. 
Culture medium containing 10% FBS was added to the 
lower compartment of invasion/migration chambers to 
serve as chemoattractants. The chambers were cultured at 
37°C in 5% CO2 in the presence or absence of ethanol 
(100 mg/dl) for 12 hours. The invaded/migrated cells 
were fixed in 4% paraformaldehyde and stained with 0.5% 
crystal violet in 2% ethanol. Membranes were washed 
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and the dye was eluted with 10% acetic acid. Absorbance 
was measured at 595 nm using a microtiter plate reader 
(Beckman coulter).
Anchorage-independent colony formation
Anchorage-independent colony formation was 
assayed as previously described [36]. Briefly, 5,000 
cells were mixed with 0.3% agar in culture medium. 
The mixture was plated on the top of 1% agar in six-
well plates with an addition of 1 ml of medium. The 
medium was changed every 3 to 4 days. The cultures were 
incubated for a month at 37°C in 5% CO2, and stained 
with 0.5 ml of 0.005% Crystal Violet. Colonies (diameter 
≥ 0.1 mm) were counted using a dissecting microscope, 
and images were captured using a Zeiss Axiovert 40C 
photomicroscope.
Assaying Stem-like cell population assay
The stem-like tumor cells were identified by 
measuring aldehyde dehydrogenase (ALDH) activity 
(ALDEFLUOR assay). The ALDEFLUOR assay was 
performed according to the manufacturer’s protocol 
(Stemcell Technologies). ALDH enzymatic activity was 
determined by flow cytometry as previously described 
[37, 38]. Briefly, after chronic exposure to ethanol (0, 
100 or 200 mg/dl), cells were collected and 106 cells 
were incubated in ALDEFLUOR assay buffer containing 
ALDH substrate (1 μmol/l per 1 × 106 cells) for 40 
minutes at 37°C. Some cells were treated under identical 
conditions with a specific ALDH inhibitor (50 mmol/l, 
diethylaminobenzaldehyde) as a negative control. Cells 
were sorted using a flow cytometer (FACSCalibur, Becton 
Dickinson) and analyzed using the WINMDI software. 
The results were presented relative to the controls.
siRNA and cell transfection
Transient transfection of RhoC siRNA (RhoC 
siRNA) or scrambled siRNA (Con siRNA) (San Cruz 
Biotech) was performed using a Neon Transfection 
System (Invitrogen Corporation, Carlsbad, CA) according 
to the manufacturer’s protocol. Briefly, MCF7 cells were 
exposed to ethanol (0 or 100 mg/dl) for 10 days, and then 
electroporated with Con siRNA or RhoC siRNA using a 
Neon transfection apparatus. After electroporation, cells 
were incubated for 48 hours, and then assayed for cell 
migration/invasion in the presence or absence of ethanol 
(100 mg/dl).
Xenograft tumor model
Ten week-old athymic nude (NU/NU) mice (Harlan 
Laboratories) were used in this experiment. All procedures 
were performed in accordance with the guidelines set by 
the National Institutes of Health (NIH) Guide for the 
Care and Use of Laboratory Animals and were approved 
by the Institutional Animal Care and Use Committee. To 
test the tumorigenicity, MCF7 cells (103 - 106 cells/100 μl 
PBS) that were exposed to ethanol (0 or 100 mg/dl) were 
subcutaneously inoculated into both sides of the lower 
flank of nude mice. For each group, there were six mice. 
One month after the inoculation, tumors in each mouse 
were determined. To determine the effect of p38γ MAPK 
knock-down on the growth of tumors, MCF7 stably 
expressing control shRNA or p38γ shRNA were exposed 
to ethanol (0 or 100 mg/dl) for a month. These cells (5 × 
106 cells/100 μl PBS) were inoculated in to nude mice. 
Tumor size was measured weekly using a caliper. Tumor 
volumes were calculated using the formula: volume 
(mm3) = (length x width2)/2. Mice were euthanized 
approximately one month after injection. Metastases in 
lung were analyzed as previously described [18].
Immunohistochemical staining
Immunohistochemical (IHC) staining was 
performed as described [18]. Briefly, tumor tissues and 
lungs were removed and fixed with 4% paraformaldehyde 
and then transferred to 30% sucrose. Tissues were 
sectioned at 10 μm thickness using a Cryostat Microtome 
(Thermo Scientific). Tumor tissues were stained with 
phosphorylated p38γ using Diaminobenzidine (DAB) 
kit. Briefly, tissues were incubated with 0.3% H2O2 
in methanol for 30 min at room temperature and then 
treated with 0.1% TritonX-100 for 10 min. The sections 
were washed twice with PBS and then blocked with 1% 
BSA and 0.05% TritonX-100 for 1 hour. The sections 
were incubated with phospho-p38γ antibody (1:300) 
overnight at 4°C. Negative controls were performed 
by omitting the primary antibody. After being rinsed in 
PBS, sections were incubated with a biotinylated goat 
anti-rabbit IgG (Vector Laboratories, Burlingame, CA) 
for an hour at room temperature. The sections were 
washed three times with PBS and incubated with in an 
avidin-biotin-peroxidase complex (1:100) for an hour and 
developed in 0.05% 3,3′- Diaminobenzidine (Invitrogen) 
containing 0.003% H2O2 in PBS. To examine the lung 
metastasis, the sections of lung tissues were stained with 
eosin and images were recorded using an Olympus BX51 
microscope.
Statistics
Differences among treatment groups were analyzed 
using analysis of variance (ANOVA). Differences in 
which p was less than 0.05 were considered statistically 
significant. In cases where significant differences were 
detected, specific post-hoc comparisons between treatment 
groups were examined with Student-Newman-Keuls tests. 
The prevalence of lung metastasis between control and 
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